Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Hypertensive crisis in children and adolescents

T. Seeman, G. Hamdani, M. Mitsnefes,

. 2019 ; 34 (12) : 2523-2537. [pub] 20181001

Language English Country Germany

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

E-resources Online Full text

NLK ProQuest Central from 1996-08-01 to 1 year ago
Medline Complete (EBSCOhost) from 1996-08-01 to 1 year ago
Nursing & Allied Health Database (ProQuest) from 1996-08-01 to 1 year ago
Health & Medicine (ProQuest) from 1996-08-01 to 1 year ago
Family Health Database (ProQuest) from 1996-08-01 to 1 year ago

Hypertensive crisis is a relatively rare condition in children. However, if not treated, it might be life-threatening and lead to irreversible damage of vital organs. Clinical presentation of patients with hypertensive crisis can vary from very mild (hypertensive urgency) to severe symptoms (hypertensive emergency) despite similarly high blood pressure (BP). Individualized assessment of patients presenting with high BP with emphasis on the evaluation of end-organ damage rather than on the specific BP number is a key in guiding physician's initial management of a hypertensive crisis. The main aim of the treatment of hypertensive crisis is the prevention or treatment of life-threatening complications of hypertension-induced organ dysfunction, including neurologic, ophthalmologic, renal, and cardiac complications. While the treatment strategy must be directed toward the immediate reduction of BP to reduce the hypertensive damage to these organs, it should not be at a too fast rate to cause hypoperfusion of vital organs by an excessively rapid reduction of BP. Thus, intravenous continuous infusions rather than intravenous boluses of antihypertensive medications should be the preferable mode of initial treatment of children with hypertensive emergency.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025458
003      
CZ-PrNML
005      
20201222160226.0
007      
ta
008      
201125s2019 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00467-018-4092-2 $2 doi
035    __
$a (PubMed)30276533
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Seeman, Tomáš $u Department of Pediatrics and Biomedical Center, 2nd Faculty of Medicine and Faculty of Medicine in Pilsen, Charles University in Prague, V Uvalu 84, 15006, Prague 5, Czech Republic. tomas.seeman@lfmotol.cuni.cz. Motol University Hospital, V Uvalu 84, 15006, Prague 5, Czech Republic. tomas.seeman@lfmotol.cuni.cz.
245    10
$a Hypertensive crisis in children and adolescents / $c T. Seeman, G. Hamdani, M. Mitsnefes,
520    9_
$a Hypertensive crisis is a relatively rare condition in children. However, if not treated, it might be life-threatening and lead to irreversible damage of vital organs. Clinical presentation of patients with hypertensive crisis can vary from very mild (hypertensive urgency) to severe symptoms (hypertensive emergency) despite similarly high blood pressure (BP). Individualized assessment of patients presenting with high BP with emphasis on the evaluation of end-organ damage rather than on the specific BP number is a key in guiding physician's initial management of a hypertensive crisis. The main aim of the treatment of hypertensive crisis is the prevention or treatment of life-threatening complications of hypertension-induced organ dysfunction, including neurologic, ophthalmologic, renal, and cardiac complications. While the treatment strategy must be directed toward the immediate reduction of BP to reduce the hypertensive damage to these organs, it should not be at a too fast rate to cause hypoperfusion of vital organs by an excessively rapid reduction of BP. Thus, intravenous continuous infusions rather than intravenous boluses of antihypertensive medications should be the preferable mode of initial treatment of children with hypertensive emergency.
650    _2
$a mladiství $7 D000293
650    _2
$a antihypertenziva $x aplikace a dávkování $x škodlivé účinky $7 D000959
650    _2
$a krevní tlak $x účinky léků $7 D001794
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a lidé $7 D006801
650    _2
$a hypertenze $x farmakoterapie $x etiologie $x patofyziologie $7 D006973
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a nemoci ledvin $x komplikace $7 D007674
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Hamdani, Gilad $u Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
700    1_
$a Mitsnefes, Mark $u Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
773    0_
$w MED00003733 $t Pediatric nephrology (Berlin, Germany) $x 1432-198X $g Roč. 34, č. 12 (2019), s. 2523-2537
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30276533 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222160222 $b ABA008
999    __
$a ok $b bmc $g 1599603 $s 1116144
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 34 $c 12 $d 2523-2537 $e 20181001 $i 1432-198X $m Pediatric nephrology $n Pediatr Nephrol $x MED00003733
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...